Analyst’s Take on These Shares: Valeant Pharmaceuticals International, Inc. (NYSE:VRX), The Coca-Cola Co (NYSE:KO)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) shares have a current ABR (average broker recommendation) of N/A. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.

Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX). The highest current target is $N/A. The lowest price target out of the polled analysts is presently $N/A. The consensus target price is currently noted at $N/A. Analysts may employ various techniques to help predict future stock price levels.

On the earnings front, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is expected to post quarterly earnings per share of $N/A. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around N/A. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) most recently reported quarterly EPS of $N/A for the quarter ending N/A. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of N/A%.

For the current quarter, analysts are expecting The Coca-Cola Co (NYSE:KO) to report EPS of $0.49. This consensus estimate is provided by Zacks Research. After the period that ended on 2017-06-30, The Coca-Cola Co (NYSE:KO) reported an EPS actual of $0.59. The difference between the actual and estimate resulted in a surprise factor of 3.51%. The company is expected to release their next earnings report on or around 2017-10-25. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of The Coca-Cola Co (NYSE:KO) have a current ABR or average broker rating of 2.6. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of The Coca-Cola Co (NYSE:KO) is $47.769. The top analyst target is $52, and the lowest target is $42 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

Leave a Comment